Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CHFS - CHF Solutions Inc. to Present at the Ladenburg Thalmann's 2019 Healthcare Conference on September 24 2019


CHFS - CHF Solutions Inc. to Present at the Ladenburg Thalmann's 2019 Healthcare Conference on September 24 2019

EDEN PRAIRIE, Minn., Sept. 19, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton, the company’s CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019 at 4:00 PM ET in Track 6 of the Madeleine Room.  The conference will be held September 24-25 at the Sofitel in New York City.

For those interested in attending the conference or arranging a one-on-one meeting with management, please contact conference organizers at HealthcareConference@Ladenburg.com or Bret Shapiro of CORE IR at 516-222-2650 or at brets@coreir.com.

About CHF Solutions
CHF Solutions, Inc. (Nasdaq:CHFS) is a medical device company focused on developing, manufacturing and commercializing the Aquadex FlexFlow® system for aquapheresis therapy. The Aquadex FlexFlow system is a clinically proven therapy that provides a safe, effective, and predictable method of removing excess sodium and fluid from patients suffering from fluid overload. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company is dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovative. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

CONTACTS:

INVESTORS:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205
ir@chf-solutions.com
-or-
Bret Shapiro
Managing Partner
CORE IR
516-222-2560
brets@coreir.com
www.coreir.com
MEDIA
Jules Abraham
JQA Partners, Inc.
917-885-7378
jabraham@jqapartners.com

Stock Information

Company Name: Nuwellis
Stock Symbol: CHFS
Market: NASDAQ
Website: nuwellis.com

Menu

CHFS CHFS Quote CHFS Short CHFS News CHFS Articles CHFS Message Board
Get CHFS Alerts

News, Short Squeeze, Breakout and More Instantly...